Screening Key Compound in Ligusticum chuanxiong Hort. for Anti‐Parkinson's Disease Based on an Experimental and Computational Framework
Chemistry & Biodiversity · 2026-03 · 23 (3)
DOI: 10.1002/cbdv.202503207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 02.03.2026. Verfasst von Xin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, China. Hauptthemen laut MEDLINE: Ligusticum, Parkinson Disease, Antiparkinson Agents, Benzofurans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: HOME Program of Gansu Province, Yunnan Province Major Scientific and Technological Project, Sichuan Science and Technology Program.
Abstract (Originalsprache)
Ligusticum chuanxiong Hort. (CX), a traditional herbal plant, has demonstrated significant therapeutic potential for treating neurological disorders. However, systematic studies screening its key active compounds for Parkinson's disease (PD) have been limited. This study aims to comprehensively identify the primary anti‐PD compounds derived from CX by integrating computational and experimental approaches, including network pharmacology, HPLC analysis, spectrum‐effect relationships, and molecular docking, alongside cellular and animal model validation. Our findings indicate that among the three CX extracts tested, CXEO (essential oil of CX) exhibited the most potent anti‐PD activity. Spectrum‐effect relationship analysis, validated through experimental studies, identified Senkyunolide A as the key active compound in CXEO. Network pharmacology analysis, further supported by validation using the GEO database, revealed tumor necrosis factor (TNF), interleukin 1β (IL‐1β), intercellular adhesion molecule 1 (ICAM1), vascular cell adhesion molecule‐1 (VCAM1), and prostaglandin endoperoxide synthase 2 (PTGS2) as the primary molecular targets through which Senkyunolide A exerts its anti‐PD effects, suggesting that its mechanism of action may involve modulation of inflammatory pathways. Additional investigation into differentially expressed genes related to PD, based on the GEO database, further confirmed the clinical relevance of Senkyunolide A in PD. These findings suggest that Senkyunolide A from L. chuanxiong Hort. holds potential as a therapeutic compound for PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, China.
- CAS Key Laboratory of Chemistry of Northwestern Plant Resources and Key Laboratory of Natural Medicine of Gansu Province, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (CAS), Lanzhou, China.
- Institute of Traditional Chinese Medicine Pharmacology and Toxicology, Sichuan Academy of Chinese Medicine Sciences, Chengdu, China.
ORCID-Profile: Dong Pei
Förderung
- HOME Program of Gansu Province
- Yunnan Province Major Scientific and Technological Project
- Sichuan Science and Technology Program
- Graduate Research and Innovation Projects of Gansu Province
- Gansu Science Fund for Basic Creative Research Groups
- Transformation Program of Scientific and Technological Achievements of Jiangsu Province
Zitieren
APA
Wang, X., Tan, Z., Hai, J., Jin, X., Di, D. L., & Pei, D. (2026). Screening Key Compound in Ligusticum chuanxiong Hort. for Anti‐Parkinson's Disease Based on an Experimental and Computational Framework. Chemistry & Biodiversity, 23(3). https://doi.org/10.1002/cbdv.202503207
Vancouver
Wang X, Tan Z, Hai J, Jin X, Di DL, Pei D. Screening Key Compound in Ligusticum chuanxiong Hort. for Anti‐Parkinson's Disease Based on an Experimental and Computational Framework. Chemistry & Biodiversity. 2026;23(3). doi:10.1002/cbdv.202503207
BibTeX
@article{Wang2026,
author = {Wang, Xin and Tan, Zhenghuai and Hai, Jun and Jin, Xiaojie and Di, Duo-Long and Pei, Dong},
title = {Screening Key Compound in Ligusticum chuanxiong Hort. for Anti‐Parkinson's Disease Based on an Experimental and Computational Framework},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {3},
doi = {10.1002/cbdv.202503207}
}
EUVIMED